Collaborations & Alliances
Related Searches:
Filter by:
556 - 570 of 1095 results
August 24, 2010
Aileron Therapeutics and Roche have entered into a collaboration to discover, develop and commercialize a new class of drugs called Stapled Peptide Therapeutics.
Read More »
August 24, 2010
3SBio, Inc. and Isotechnika Pharma, Inc. have signed a development and commercialization agreement for voclosporin, a next-gen calcineurin inhibitor being developed for the prevention of organ rejection and the treatment of autoimmune diseases.
Read More »
August 19, 2010
Novozymes Biopharma and SAFC, a member of the Sigma-Aldrich Group, have extended by 10 years their joint agreement for LONG R3.
Read More »
August 18, 2010
Quark Pharmaceuticals has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002 currently in Phase II development.
Read More »
August 12, 2010
NextWave Pharmaceuticals and Tris Pharma have entered a collaboration agreement under which Tris Pharma will use its drug delivery technology for liquid and solid formulations to enhance NextWave's CNS product portfolio.
Read More »
August 10, 2010
Sanofi-Aventis and Scripps Genomic Medicine (SGM) entered a strategic alliance to advance R&D initiatives in the field of personalized medicine.
Read More »
August 10, 2010
Scancell Holdings and Cancer Research Technology, Ltd. (CRT) have signed an agreement under which Scancell has been granted a license to use a human antibody known as 105AD7.
Read More »
August 5, 2010
CDMO will provide solutions for unique prostate cancer treatment.
Read More »
August 3, 2010
Seattle Genetics and Genentech have expanded their antibody-drug conjugate (ADC) collaboration.
Read More »
July 29, 2010
Aptuit, Inc. and Siena Biotech entered into a strategic partnership under which Siena Biotech will take a minority stake in Aptuit’s operations in Verona, Italy and Aptuit will serve as Siena’s provider of choice for its development pipeline.
Read More »
July 28, 2010
Astellas has extended its non-exclusive license agreement through 2023 to use Regeneron's VelocImmune technology for its research programs to discover fully human monoclonal antibody product candidates.
Read More »
July 23, 2010
Firms to collaborate on EU patient registries and real-world studies
Read More »
July 14, 2010
Pfizer and Samsung Medical Center (SMC) have formed a research partnership to jointly analyze tumors from Korean patients to generate gene expression profiles in an effort to direct therapies and enhance clinical outcomes in the patients with liver cancer
Read More »
July 14, 2010
Jonathan M Fishbein, M.D. has been appointed vice president and Global Head for the Infectious Disease & Vaccines Therapeutic Group at ICON Clinical Research.
Read More »
July 14, 2010
Aestus Therapeutics and Eisai have entered into a collaboration to research and develop therapeutics for the treatment of psychiatric disorders.
Read More »
556 - 570 of 1095 results
